Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- Kuala Lumpur
- Most recent report
- 8-K, filed Oct 7, 2026
- Incorporated
- Wyoming
- Filings on record
- 156 filings
- On EDGAR
- CIK 1737523
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 38
News 8 of 51
Prospectuses and Registrations 8 of 9
- S-3 Shelf registration statement Nov 7, 2025
- 424B4 Final prospectus for an offering Jul 21, 2023
- S-1/A Registration statement for an offering, amended Jul 17, 2023
- S-1/A Registration statement for an offering, amended Jul 5, 2023
- S-1/A Registration statement for an offering, amended May 9, 2023
- S-1 Registration statement for an offering Feb 14, 2023
- S-1/A Registration statement for an offering, amended Mar 27, 2019
- S-1/A Registration statement for an offering, amended Feb 25, 2019
Proxies 7
- DEF 14A Proxy statement for a shareholder vote Dec 3, 2025
- PRE 14A Preliminary proxy statement Nov 14, 2025
- DEFR14A Feb 28, 2025
- DEF 14A Proxy statement for a shareholder vote Feb 27, 2025
- PRE 14A Preliminary proxy statement Feb 10, 2025
- DEF 14A Proxy statement for a shareholder vote Sep 16, 2024
- PRE 14A Preliminary proxy statement Sep 6, 2024
Ownership 8 of 24
- SCHEDULE 13D Large holder reported an active stake Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 3 Insider reported their initial holding Aug 7, 2026
- 3 Insider reported their initial holding Jul 31, 2026
Other 8 of 27
- NT 10-K Notice that an annual report will be late Mar 31, 2026
- NT 10-Q Notice that a quarterly report will be late Aug 14, 2025
- NT 10-K Notice that an annual report will be late Mar 31, 2025
- NT 10-Q Notice that a quarterly report will be late Nov 14, 2024
- UPLOAD Comment letter from SEC staff Jun 6, 2024
- CORRESP Reply to SEC staff May 23, 2024
- UPLOAD Comment letter from SEC staff May 6, 2024
- NT 10-K Notice that an annual report will be late Mar 28, 2024
Everything here comes from BioNexus Gene Lab Corp's own filings on SEC EDGAR. The filing list is rechecked every hour.